We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 115

Patent settlements under the authorities’ magnifying glass
  • Bird & Bird
  • European Union
  • December 15 2009

Drug prices are currently a key area of discussion in many countries around the globe


End of German Olanzapine battle: Federal Supreme Court upholds patent
  • Bird & Bird
  • Germany
  • March 11 2009

On December 16, 2008 the Federal Supreme Court gave its judgment determining the validity of the Olanzapine patent, this was further to its revocation by the Federal Patent Court at first instance


New regulations for medical devices
  • Bird & Bird
  • Spain
  • December 15 2009

On 6 November 2009, two new regulations reshaping the framework for medical devices were published in the Spanish Official Gazette


Paedriatric SPC extension: zero or negative term SPCs
  • Bird & Bird
  • European Union, United Kingdom
  • March 11 2009

Zero or negative term SPCs give rise to a unique disunity amongst the granting authorities in the European Member States


UK Patents Court judgment in Laboratorios Almirall SA v Boehringer Ingelheim International GmbH
  • Bird & Bird
  • United Kingdom
  • March 11 2009

This case concerned a tit-for-tat revocation of two patents claiming the combinations of a particular anticholinergic with -agonists for treating respiratory illnesses


Corevalve Inc. v. Edwards Lifesciences AG & Edwards Lifesciences PVT, Inc
  • Bird & Bird
  • United Kingdom
  • March 11 2009

Edwards Lifesciences, the world leader in replacement heart valves, succeeded in upholding the validity of their patent for a transcatheter valve


Federal Supreme Court of Germany decides on second medical use claims that relate to dosage recommendations
  • Bird & Bird
  • Germany
  • May 29 2007

In the decision Carvedilol II (file X ZR 23601), the Federal Supreme Court had to deal with the validity of the German part of a European patent that was defended with a main claim, the essential part of which reads as follows: “Use of Carvedilol for the manufacture of a medicament , wherein the medicament is administered in an initial dose of 3.125 mg , daily for a period of 7- 28 days .”


ECJ decision in AHP Manufacturing BV v the Bureau voor de Industriele Eigendom (Case C-48207)
  • Bird & Bird
  • European Union
  • October 13 2009

The ECJ has accepted that the holder of a basic patent is entitled to one SPC regardless of whether other SPCs have already been granted to other holders of one or more other basic patents


The future of the Belgian kiwi reimbursement model jeopardised by a decision of the Council of State?
  • Bird & Bird
  • Belgium
  • July 17 2009

In 2006, Belgium implemented a procedure for the reimbursement of medicinal products that was inspired by the system applicable in New Zealand, known also as the "kiwi model"


Patents Court judgment in Ratiopharm GmbH and Sandoz Limited v Napp Pharmaceutical Holdings Limited
  • Bird & Bird
  • United Kingdom
  • March 11 2009

The Patents Court (Mr Justice Floyd) handed judgment down on 16 December 2008 relating to two patents regarding formulations to achieve slow release of the opioid pain killing drug, oxycodone